Oskar Slotboom Overview

  • Primary Position
  • Managing Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 4

  • Med. Deal Size

  • Med. Valuation

Oskar Slotboom General Information

Biography

Mr. Oskar Slotboom serves as Managing Partner at BioGeneration Ventures. He also serves as Member of Supervisory Board at VarmX. He serves as Board Member at Mironid, Dunad Therapeutics, and Catalym. He served as a Supervisory Board Member at Mellon Medical. He joined BioGeneration as a partner in 2016 strengthening the team with his commercial, business development and consulting experience. He started his career in McKinsey & Company as a management consultant. After that he held positions in Crucell first as business development director and later he became responsible for the Pediatric Franchise. After the acquisition of Crucell by Johnson & Johnson, he led the Vaccines & Infectious Diseases business unit in Johnson & Johnson's pharma joint venture Xian Janssen in Beijing, China. Prior to joining BioGeneration he was Chief Commercial Officer of Avantium, a leading chemical technology company and a forerunner in renewable chemistry. He has a degree in chemical engineering from the Twente University (NL) and holds a MBA from INSEAD.

Contact Information

Primary Position
Managing Partner, BioGeneration Ventures
Education
University of Twente, Degree
INSEAD, MBA (Master of Business Administration)
Gender
Male
Email
os
Phone
+31 035
Address
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
+31 035

Oskar Slotboom Positions (2)

Firm name Firm type Title Location Industry Since
BioGeneration Ventures Investor Managing Partner Naarden, Netherlands Venture Capital
VarmX Company Member of Supervisory Board Leiden, Netherlands Drug Discovery

Oskar Slotboom Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
Catalym Drug Discovery Privately Held (backing) Venture Capital-Backed Planegg, Germany
Dunad Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Mellon Medical Surgical Devices Privately Held (backing) Venture Capital-Backed Delft, Netherlands
Mironid Therapeutic Devices Privately Held (backing) Venture Capital-Backed Newhouse, United Kingdom

Oskar Slotboom Lead Partner on Deals (10)

Oskar Slotboom has been the lead partner on 10 deals. Their latest deal was with Catalym, a drug discovery company. The deal was made for on 22-Nov-2022.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Catalym 22-Nov-2022 Later Stage VC (Series C) Completed Drug Discovery Planegg, Germany
Dunad Therapeutics 02-Nov-2021 Completed Drug Discovery Cambridge, United Kingdom
Catalym 10-Nov-2020 Completed Drug Discovery Planegg, Germany
VarmX 03-Jul-2020 Completed Drug Discovery Leiden, Netherlands
Mellon Medical 12-Jun-2020 Completed Surgical Devices Delft, Netherlands
VarmX 02-Jul-2018 Completed Drug Discovery Leiden, Netherlands
NorthSea Therapeutics 12-Dec-2017 Completed Drug Discovery Amsterdam, Netherlands
Mellon Medical 02-Oct-2017 Completed Surgical Devices Delft, Netherlands
Mironid 31-Aug-2017 Early Stage VC Completed Therapeutic Devices Newhouse, United Kingdom
VarmX 27-Jun-2017 Seed Round Completed Drug Discovery Leiden, Netherlands

Oskar Slotboom Network (115)

Board Members (54)

Name Company Representing Location From
Jonathan Leff MD NorthSea Therapeutics Sofinnova Investments Amsterdam, Netherlands
Colleen Cuffaro Ph.D Catalym Canaan Partners Planegg, Germany
Dunad Therapeutics Dunad Therapeutics Cambridge, United Kingdom
NorthSea Therapeutics NorthSea Therapeutics Amsterdam, Netherlands
Mellon Medical BioGeneration Ventures Delft, Netherlands

Portfolio Executives (57)

Name Company Role Deal date Location
Jörg Wischhusen Ph.D Catalym Co-Founder & Acting Chief Scientific Officer 22-Nov-2022 Planegg, Germany
Eugen Leo MD Catalym Chief Medical Officer 22-Nov-2022 Planegg, Germany
Catalym Chief Executive Officer 22-Nov-2022 Planegg, Germany
Catalym Chief Executive Officer 22-Nov-2022 Planegg, Germany
Catalym Chief Financial Officer 22-Nov-2022 Planegg, Germany

Fund Team Members (4)

Name Investor Fund Fund Location
Rianne Ellenbroek Ph.D BioGeneration Ventures BioGeneration Capital Fund IV Naarden, Netherlands
Edward Wezel BioGeneration Ventures BioGeneration Ventures III Naarden, Netherlands
BioGeneration Ventures Naarden, Netherlands
BioGeneration Ventures Naarden, Netherlands
BioGeneration Ventures Naarden, Netherlands

Oskar Slotboom Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
BioGeneration Ventures III BioGeneration Ventures Venture Capital - Early Stage Closed 2016
BioGeneration Capital Fund IV BioGeneration Ventures Venture Capital - Early Stage Closed 2021

Oskar Slotboom FAQs

  • Who is Oskar Slotboom?

    Mr. Oskar Slotboom serves as Managing Partner at BioGeneration Ventures.

  • How much does Oskar Slotboom typically invest?

    Oskar Slotboom's median deal size is .

  • What is Oskar Slotboom’s main position?

    Oskar Slotboom’s primary position is Managing Partner.

  • What are the contact details for Oskar Slotboom?

    Oskar Slotboom’s email address is os and his phone number is +31 035 .

  • How many active board seats does Oskar Slotboom hold?

    Oskar Slotboom holds 4 board seats including Catalym, Dunad Therapeutics, Mellon Medical, and Mironid.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »